A continuing search for tumor inhibitors from plant sources has yielded over two hundred extracts with reproducible growth-inhibitory activity. Systematic fractionation, guided by assay in cell culture and animal tumor systems, has led to the isolation of the active principles of more than sixty plants. Chemical studies of novel sesquiterpene Iactones, diterpenoid quinone methides, steriod Iactones and other terpenoid tumour inhibitors are discussed.
INTRODUCTION
The past two decades have witnessed the synthesis of many hundreds of chemical variants of known classes of cancer chemotherapeutic agents. Synthesis of modifications of presently-known drugs does (and should) continue. However, some pessimism is evident among workers in the field, because of the relatively small improvements over the prototype drugs which have resulted from the extensive synthetic efforts to date. There exists a need for new prototypes, or templates, for the synthetic organic ehernist to use in the design of potentially superior chemotherapeutic agents. As a corollary statement, there exists a need for elucidation of new biochemical mechanisms of growth regulation which may be more amenable to selective regulation. Recent studies in the isolation and structural elucidation oftumor inhibitors are yielding a fascinating array ofnovel types of growth-inhibitory compounds. There appears to be reason for confidence that this approach may point the way to useful templates for new synthetic approaches to cancer chemotherapy.
Studies ofplant-derived tumor inhibitors are proceeding in many laboratories ofwide geographic distribution. However, to limit the scope ofthe present discussion, the author will review only recent studies of terpenoid tumor inhibitors from his own laboratory at the University ofWisconsin.
The programme at the University of Wisconsin started modestly, in 1959, with a screening study of crude extracts of a limited number of accessible plants for inhibitory activity against animal-tumor systems. Some plants were procured by summer collections in Wisconsin, others by cooperative arrangements with botanists in India, Costa Rica, and other countries. The results of testing of the first plant extracts prepared in our laboratory and elsewhere revealed that a small but significant number of the extracts showed reproducible tumor-inhibitory activity. Encouraged by these results, the Cancer Chemotherapy National Service Center of the National Institutes ofHealth arranged with the U.S. Department of Agriculture toprocure several thousand plant samples per year for evaluation. Shortly thereafter, the CCNSC arranged a contract with the Wisconsin Alumni Research Foundation, in Madison, to execute the initial extraction and screening studies. From that point onward, the University of Wisconsin programme concentrated on the isolation and structural elucidation of new tumor inhibitors. To date, the active principles of more than sixty active plants have been isolated in the Wisconsin programme, and the chemical studies of some of the most interesting compounds constitute the focus of this review.
ISOLATION OF TUMOR-INBIBITORY PRINCIPLES FROM PLANTS
One aspect of the approach of our programme differs significantly from the classical, and most widely practiced, approach to the biological study of plant constituents. In the classical phytochemical approach, those compounds are studied which are most easily separated from a plant extract and most easily crystallized. In our programme, however, the fractionation and isolation sturlies are guided at every stage by biological assays. The systematic fractionation, guided by biological assays, has made possible the isolation of important minor constituents which would most probably have been missed in the classical approach.
Solanum dulcamara L.
Solanum dulcamara L., collected near Madison, Wisconsin, was one of the first plants found active in the Wisconsin programme. Figure 1 summarizes the fractionation procedure which led to isolation of the tumor-inhibitory principle, the steroid alkaloid glycoside ß-solamarine, whose structure is shown in Figure 2 . I t is noteworthy that S. dulcamara L. has been used to treat cancers, tumors, and warts from the time of Galen (c. A.D. 180), and references to its use have appeared in the Iiterature of many countriesl.
Marah oreganus and Brandegea bigelovii Cogn.
Systematic fractionation of an exceedingly cytotoxic extract from Marah oreganus (Cucurbitaceae), from California, led to isolation of the four previously-known cucurbitacins shown in Figure 3 2. Similar fractionation of a cytotoxic extract of Brandegea bigelovii Cogn. ( Cucurbitaceae) gave three new cucurbitacins, 0, P, and Q. The structures were deduced from their formulae and spectra. Interrelation was accomplished by conversion of both cucurbitacins 0 and Q to cucurbitacin P, which was also prepared from cucurbitacin B. Gonversion of cucurbitacin P to a 2,3-acetonide showed that it was the 3ß-hydroxy-epimer of dihydrocucurbitacin F, thus confirming its absolute configuration. The interrelationships showed that cucurbitacin 0 was 3-epi-cucurbitacin Fand cucurbitacin Q its 25-acetate derivative ( Figure  4 Taxodium distichum Rich. Systematic sturlies of a tumor-inhibitory extract from Taxodium distichum Rich led to isolation and structural elucidation of two novel diterpenoid quinone methides, taxodione (I) and taxodone (V) ( Figure 5 ) 4 • The structures were deduced from their formulae and spectra, and confirmed by inter- relation with a known diterpene. Both quinone methides were converted toll, which was methylated to III. Reduction of 111 with Iithium aluminium hydride gave the 6ß-alcohol IV, which was dehydrated to VI. Catalytic hydrogenation ofVI gave VII, characterized by direct comparison with a sample prepared from sugiol (VIII). Among the six di terpenoid derivatives isolated from Taxodium distichum only the quinone methide derivatives taxodione and taxodone showed significant inhibitory activity in vivo agairrst the Walker carcinosarcoma 256 in the rat and in vitro agairrst cells derived from human carcinoma of the nasopharynx (KB). This fact and the known sensitivity of quinone methides to nucleophilic attack5· suggested that taxodione and taxodone might exert their biological effect by interaction with a biological nucleophile at C-7. The plausibility of the· suggestion was supported by the recent finding that both diterpenoid quinone methides are powerful inhibitors of the sulphydryl enzyme, phosphofructokinase6.
Acnistus arborescens L. Schlecht
The leaves of Acnistus arborescens (L.) Schlecht have been used for many years to treat cancerous growths, and an extract of the leaves was forwarded to us by Professor J. A. Saenz Renauld, of the University of Costa Rica.
Fractionation by the procedure outlined in Figure 6 spectral, and x-ray crystallographic sturlies resulted in elucidation of the structure shown in Figure 7 for withaferin A 7. While our work was in progress, Professor David Lavie and his coworkers independently reported the isolation and structural elucidation of withaferin A from Withania somnifera L.S. Withaferin A was the prototype of a novel dass of polyfunctional steroid Iactones, the withanolides. Further chemical and biological sturlies are under way.
Elephantopus elatus Bertol.
A systematic study of the cytotoxic principles of Elephantopus elatus Bertol. led to the isolation of two novel tumor-inhibitory germacranolide dilactones, elephantin and elephantopin9. Although the compounds were concentrated and isolated solely on the basis of in vitro cytotoxicity, elephantopin has ~ubsequently been found to show significant inhibitory activity against the P-388 lymphocytic leukemia in the mouse and Walker carcinosarcoma 256 in the rat. (The KB cytotoxicity assay has been invaluable in many other of isolation studies as well. Significant results were frequently obtained from the bioassay of 2 to 10 mg samples of materials which could be evaluated in in vivo animal tumor systems only at the cost of 0·5 to 1 g samples.) A combination of degradative, spectral, and x-ray crystallographic sturlies resulted in elucidation of the structures of elephantin and elephantopin shown in Eupatorium rotundifolium L. initially yielded the new and novel guaianolide tumor inhibitors euparotin and euparotin acetate. Preliminary chemical and spectral characterization revealed that euparotin could be readily acetylated to euparotin acetate without structural rearrangement. Consequently, euparotin was acylated with bromoacetic anhydride to yield the nicely crystalline derivative, euparotin bromoacetate. X-ray crystallographic analysis ofthe bromoacetate by Professor G. A. Sim and Dr. A. T. McPhail established (some three and one-half weeks later) that the bromoacetate has the structure depicted in Figure 9 (with R = COCH2 Br), and it follows determined by interrelation with the x-ray defined structure of euparotin acetatell, 12. For example, eupachlorin acetate, C 22 H 2 7ClOs, showed spectral characteristics indicative of the presence of an angelate ester, an a,ß-unsaturated Iactone with an exocyclic methylene group, an allylic acetate, and the absence of an exocyclic-epoxide-methylene grouping. Location of the chlorine atom on the C-14 methylene group was supported by the downfield shift of the signal assigned to the C-14 methylene protons ( r 6·47) relative to the signal for the C-14 methylene protons ( r 7·32) in the n.m.r. spectrum of euparotin acetate. Two D20-exchangeable hydroxyl proton signals were detected in contrast to one in euparotin acetate's spectrum. The tertiary nature of these hydroxyl functions was indicated by their resistance to acetylation upon treatment with acetic anhydride and pyridine. These data were consistent with the structural formula depicted in the upper right corner of Figure 10 . Chromatograpny of eupachlorin acetate upon acidwashed alumina resulted in transformation to euparotin acetate in 65 per cent yield. This interrelation proved the functional group pattern, stereochemistry, and absolute configuration of eupachlorin acetate. Incidentally,. eupachlorin acetate and its companions, eupachlorin and eupachloroxin, are the first reported chlorine-containing sesquiterpenes.
Vernonia hymenolepis A. Rich Recent studies of Vernonia hymenolepis A. Rich led to isolation and structural elucidation of two novel elemanolide dilactones, vernolepin and vernomenin. Vernolepin showed significant in vitro cytotoxicity and in vivo tumor inhibitory activity agairrst the Walker 256 carcinosarcoma in the rat. Eiemental analysis and mass spectrometry indicated a C1sH16Üs molecular formula for vernolepin. Chemical and spectral evidence indicated the presence of two a,ß-unsaturated Iactone functions, a secondary alcohol, an additional double bond, and, therefore, a monocarbocyclic ring skeleton. The structure and stereochemistry for vernolepin (R = H) depicted in the upper left of Figure 11 were established by x-ray crystallographic analysis of the p-bromobenzenesulphonate (R = S02CsH4Br). Vernomenirr showed similar chemical properties to vernolepin, and its structure was proven by (a) its conversion to the same methanol adduct as that obtained from vernolepin (lower left of Figure 11 ), and (b) a comparison of the n.m.r. spectra of the respective acetate esters (R = COCH3). In vernomenirr acetate, the triplet centred at r 4·78 could be assigned to the proton at acetate-bearing C-6, while the multiplet centred at r 5·90 corresponded to the proton (spin coupled to three protons) at lactone-bearing C-8. In contrast, the spectrum of vernolepin acetate showed a multipletat r 4·95, assigned to the proton at acetatebearing C-8, while the lactone proton signal appeared as a triplet centred at r 5·96, indicative of attachment to C-613.
Vernonia amygdalina Dei.
Vernonia amygdalina Del. has yielded a new cytotoxic sesquiterpene lactone, vernodalin. Vernodalin has been shown to be vernolepin mono-hydroxymethacrylate (Figure 12 ). Mass spectrometry indicated a C19H2o0 7 molecular formula for vernodalin. Acidic hydrolysis in methanol gave the same methanol adduct as that obtained from vernolepin. An additional interre- 
BIOLOGICAL ACTIVITY OF TUMOR-INHIBITORY PRINCIPLES
In an attempt to elucidate a possible function of a series of new plantderived tumor inhibitors, we enlisted the collaboration of Professor Luis Sequeira in an evaluation of the effects of these compounds on plant-growth. Several of the sesquiterpene dilactones, specifically elephantin, elephantopin, and vernolepin were found to be strong inhibitors of extension growth of wheat coleoptile sections15. Vernolepin inhibits extension growth in concentrations of 5 to 50 micrograms per ml (from 20 to 80 per cent, Figure 13 ).
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If the inhibited sections are washed and subsequently treated with indole-3-acetic acid, the tissues respond to the auxin, but the degree of elongation is determined by the length ofprior treatment with vernolepin (e.g., Figure 14) . The fact that vernolepin's plant growth inhibitory activity is reversible suggests that the compound may have a natural function in the regulation of plant growth. Several recent observations have focused attention on the importance of the conjugated a-methylene-lactone function for the biological activity of the sesquiterpene Iactones. For instance, the plant-growth inhibitory effect of vernolepin is completely blocked by addition of sulphydryl compounds such as mercaptoethanol to the medium. Second, vernolepin, and other sesquiterpene Iactones are potent inhibitors of the sulphydryl-bearing enzyme, phosphofructokinase6_ Third, as shown inFigure 15, the cytotoxicity of vernolepin derivatives appears to be directly related to the presence of free conjugated a-methylene-lactone functions. Thus, selective reduction of the ethylidene double bond (vide infra) does not appear to affect the cytotoxicity.
However, modification of the a-methylene-y-lactone (by transesterification to the methanol adduct or by hydrogenation) results in a 10-fold diminution in cytotoxicity. Modification of both a-methylene-lactone systems, as in hexahydrovernolepin, Ieads to a derivative which is essentially inactive.
The synthesis of dihydrovernolepin exemplifies a new blocking sequence for the protection of the highly reactive conjugated a-methylene groups of Iactones. Vernolepin was treated with an excess of n-propyl thiol at pH 9·2 to give a bis-thiol-adduct. Hydrogenation of the bis-thiol-adduct (with one mole-equivalent of hydrogen) followed by methyl iodide methylation and sodium bicarbonate-catalysed elimination, gave dihydrovernolepinl6. Wehave recently studied the reactions ofseveral conjugated a-methylenelactones with model biological nucleophiles. For instance, the rates of the reactions of vernolepin and elephantopin with cysteine at pH 7·4 were determined spectrophotometrically (Figure 16) . The most reactive function in each case was the conjugated a-methylene-y-lactone, and the second order rate constants for the 'Michael-type' addition of cysteine showed the same order of reactivity towards cysteine as iodoacetate, a commonly-used sulphydryl reagent. In contrast to the reactivity of the Iactones towards sulphydryl groups, their reaction with amino groups appeared to be very slow. When a solution equimolar in Iysine and vernolepin at pH 7·4 was allowed to stand for 6 days at 25°, 75 per cent of the original Iactone could be recovered. Similarly, guanine proved unreactive toward either vernolepin or elephantopin. The bis-cysteine-adducts, in accord with expectation, were essentially inactive17.
A search for the cytotoxic principle of Asclepias curassavica L. led to isolation and characterization of calotropin (Figure 17 In a parallel study, the cardenolide glycosides apocannoside and cymarin ( Figure 18) were identified as the cytotoxic principles of Aporynum cannabinum L,l9. At this point, Professor L. E. Hokin, of the University of Wisconsin Medical School, enlisted our collaboration in a search for a selective irreversible inhibitor oftransport ATPase. Ouabain and strophanthin had long been known to effect powerful and highly specific reversible inhibition of the ATPase. We undertook to modify the strophanthin molecule in the search for an irreve"rsible inhibitor. Our first studies of the chemistry vs. the biological activity of cardenolides as cytotoxic agents, cardiotonic agents, and ATPase inhibitors revealed that only those compounds modified solely in Ring A retained the major proportion of biological activity20, We found that the aglycone, strophanthidin, retained most of the ATPase-inhibitory activity, and that the activity was not lessened by acetylation to strophanthidin 3-acetate (SA, Figure 19 ). We next prepared strophanthidin 3-bromoacetate (SBA) and strophanthidin 3-iodoacetate (SIA), and these were found tobe steroid with much higher affinity for the cardiotonic steroid site of the enzyme appeared desirable. In a parallel study, an investigation of Bersama ahyssinica Fresen. from Ethiopia led to isolation and characterization ofhellebrigenin 3-acetate and hellebrigenin 3,5-diacetate as the powerfully cytotoxic principles (Figure 21 When it was found that hellebrigenin has 30 times the affinity ofstrophanthidin for transport ATPase, a series ofhellebrigenin 3-haloacetates was synthesized. It was found that hellebrigenin 3-iodoacetate is IOO times more potent as an irreversible inhi bitor of the enzyme than strophanthidin 3-bromoacetate23.
Further study of the cytotoxic principles of Bersama abyssinica Fresen. has yielded a series of new bufadienolides. We recently reported the isolation and structural elucidation ofbersaldegenin I,3,5-orthoacetate, which appears to be the first recognized naturally occurring orthoacetate (Figure 22) 24 
CONCLUSION
The programme to date has demonstrated that several new types of compounds show significant growth-inhibitory activity against standard tumor systems in the National Cancer Institute's screen. Thus, for instance, steroid Iactones, sesquiterpene Iactones, and diterpenoid quinone methides represent chemical types not recognized previously as growth inhibitors.
W e are optimistic about the future of our approach, from several points ofview. First, some ofthe new natural products are showing sufficient promise in the advanced preclinical animal studies now in progress to become candidates for clinical trial in the near future. Secondly, we are encouraged by the fact that several of the new and remarkably cytotoxic compounds are showing usefulness as tools for studying biochemical phenomena. Finally, from a long-range point of view, we are hopeful that some of the unusual types of biologically-active compounds may serve significant roles as novel chemical templates for new synthetic approaches to cancer chemotherapy.
